Related Experiment Video
Updated: May 14, 2026
06:07
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
α-Synuclein and mitochondrial dysfunction in Parkinson's disease.
Stephen Mullin1, Anthony Schapira
1Department of Clinical Neurosciences, UCL, Institute of Neurology, Royal Free Campus, Pond Street, London NW3 2QG, UK. s.mullin@nhs.net
Molecular Neurobiology
|January 31, 2013
Summary
Alpha-synuclein (SNCA) aggregation is central to Parkinson's disease (PD) pathogenesis. Targeting SNCA's expression, degradation, and aggregation offers potential neuroprotective strategies for PD.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Alpha-synuclein (SNCA) is a key component of Lewy bodies, the pathological hallmark of Parkinson's disease (PD).
- Research has revealed a significant link between SNCA and PD pathogenesis, integrating biochemistry and molecular genetics.
- Familial forms of PD have implicated SNCA in various biochemical pathways crucial to the disease's development.
Purpose of the Study:
- To explore the central role of SNCA in the complex interplay of pathways leading to Parkinson's disease.
- To identify SNCA's expression, degradation, and aggregation as potential neuroprotective therapeutic targets.
Main Methods:
- Analysis of cell lines from familial Parkinson's disease cases.
- Investigation of SNCA's involvement in biochemical pathways.
- Examination of oxidative stress, mitochondrial dysfunction, and protein turnover regulation.
Main Results:
- SNCA plays a pivotal role in the pathogenesis of Parkinson's disease.
- Interactions between oxidative stress, mitochondrial dysfunction, and protein turnover impairment contribute to dopaminergic cell death.
- Manipulation of SNCA presents promising therapeutic avenues.
Conclusions:
- Parkinson's disease involves a complex network of interacting pathways where SNCA is a central player.
- Targeting SNCA's lifecycle (expression, degradation, aggregation) holds significant potential for developing neuroprotective therapies for PD.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...